Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia (Q35802635)

10 August 2017

Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia (English)

1 reference

10 August 2017

C Otto

1

1 reference

10 August 2017

K G Parhofer

2

1 reference

10 August 2017

M M Ritter

3

1 reference

10 August 2017

W O Richter

4

1 reference

10 August 2017

P Schwandt

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

5

1 reference

10 August 2017

473-478

1 reference

Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. PCVMETRA Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Highly significant negative correlations between erythrocyte aggregation value and serum concentration of high density lipoprotein cholesterol in a sample from a normal population and in patients with coronary heart disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Can rheologic variables be of prognostic relevance in arteriosclerotic diseases?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873695

Fibrinogen as a risk factor for stroke and myocardial infarction

25 September 2018

1 reference

12 December 2020

Blood viscosity--a comparative study on three rotational instruments

1 reference

12 December 2020

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

12 December 2020

Acipimox in the treatment of patients with hyperlipidaemia: a double blind trial

1 reference

12 December 2020

Coagulation factors and the progress of coronary heart disease

1 reference

12 December 2020

Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia

1 reference

12 December 2020

Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trial

1 reference

12 December 2020

Blood and plasma viscosity after acipimox treatment in hypertriglyceridemic patients

1 reference

12 December 2020

Increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia

1 reference

12 December 2020

A comparison between nicotinic acid and acipimox in hypertriglyceridaemia--effects on serum lipids, lipoproteins, glucose tolerance and tolerability

1 reference

12 December 2020

Association between rheology and components of lipoproteins in human blood. Results from the MONICA project

1 reference

12 December 2020

Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects

1 reference

12 December 2020

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

1 reference

12 December 2020

Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia

1 reference

12 December 2020

Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors

1 reference

12 December 2020

Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men

1 reference

12 December 2020

Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

12 December 2020

Seasonal variations of hemorheological and lipid parameters in middle-aged healthy subjects

1 reference

12 December 2020

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

12 December 2020

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00816.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

9833601

1 reference